Empagliflozin Improves HbA1c in Young People With T2DM ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌&nbs p;‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
Can't see the images? View as webpage.
 
To ensure that you never miss an issue, please whitelist us.
DIABETES IN CONTROL | News and Information for Medical Professionals
DIC_23Years_Badge.png
     

Global Prevalence of Diabetic Retinopathy ~7 Percent in Pediatric T2DM Patients

Global Prevalence of Diabetic Retinopathy ~7 Percent in Pediatric T2DM Patients
The prevalence of diabetic retinopathy (DR) is 6.99 percent in pediatric type 2 diabetes (T2D) and increases with time since diagnosis, according to a meta-analysis published online March 17 in JAMA Network Open.
Learn More

Mortality Reduced With Adherence to Low-Carb Diet in Type 2 Diabetes

For individuals with incident type 2 diabetes (T2D), a greater adherence to low-carbohydrate diet (LCD) patterns is associated with lower mortality, according to a study published online Feb. 14 in Diabetes Care. 
Read More
Mortality Reduced With Adherence to Low-Carb Diet in Type 2 Diabetes

Empagliflozin Improves HbA1c in Young People With T2DM
Empagliflozin Improves HbA1c in Young People With T2DM

For young people, empagliflozin is associated with improvement in glycated hemoglobin (HbA1c), according to a study published in the March issue of The Lancet Diabetes & Endocrinology. 
Uncover More

     

  dic_icon_facebook  dic_icon_twitter   dic_icon_linkedIn

©2022 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of: Diabetes In Control

2093 Philadelphia Pike #8370
Claymont, DE 19703

DiabetesInControl.com | Contact Us |  Update Profile | Unsubscribe